Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Active Biotech AB

Headquarters: Lund, Sweden
Year Founded: 1996
Status: Public
Industry Sector: HealthTechnology
CEO: Helén Tuvesson, PhD
Number Of Employees: 6
Enterprise Value: N/A
PE Ratio: -1.75
Exchange/Ticker 1: SSE:ACTI
Exchange/Ticker 2: N/A
Latest Market Cap: $9,274,514

BioCentury | Aug 10, 2018
Clinical News

Active, Teva's laquinimod misses in Phase II for HD

BioCentury | Jan 9, 2018
Finance

Stars in China

Biotech winners, losers in 4Q17
BioCentury | Jul 14, 2017
Strategy

Back to Ipsen’s roots

Why Ipsen is revving up clinical-stage BD and adding a venture fund
BioCentury | Jul 7, 2017
Finance

Onward and upward

Biotech winners, losers in 2Q17
BioCentury | Jun 21, 2017
Company News

Management tracks

BioCentury | Jun 7, 2017
Distillery Therapeutics

Cardiovascular; hematology

BioCentury | May 12, 2017
Clinical News

Teva's laquinimod fails Phase III RRMS trial

BioCentury | May 5, 2017
Clinical News

Teva's laquinimod fails Phase III RRMS study

Items per page:
1 - 10 of 249